Trial Profile
The Effect of Ticagrelor on 15-Epi-Lipoxin A4 and Inflammation
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Ticagrelor (Primary) ; Clopidogrel
- Indications Acute coronary syndromes
- Focus Pharmacodynamics
- 09 Dec 2019 Status changed from recruiting to withdrawn prior to enrolment.
- 11 Dec 2015 New trial record